GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Glaukos Corp (STU:6GJ) » Definitions » 5-Year Yield-on-Cost %

Glaukos (STU:6GJ) 5-Year Yield-on-Cost % : 0.00 (As of Sep. 25, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Glaukos 5-Year Yield-on-Cost %?

Glaukos's yield on cost for the quarter that ended in Jun. 2024 was 0.00.


The historical rank and industry rank for Glaukos's 5-Year Yield-on-Cost % or its related term are showing as below:



STU:6GJ's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.185
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Glaukos's 5-Year Yield-on-Cost %

For the Medical Devices subindustry, Glaukos's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glaukos's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Glaukos's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Glaukos's 5-Year Yield-on-Cost % falls into.



Glaukos 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Glaukos is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Glaukos  (STU:6GJ) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Glaukos 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Glaukos's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Glaukos Business Description

Traded in Other Exchanges
Address
One Glaukos Way, Aliso Viejo, CA, USA, 92656
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Glaukos Headlines

No Headlines